J Immunother Cancer
Dr. Rangaswamy Govindarajan, MD
- Medicare services, 2024
- 453
- Medicare patients, 2024
- 174
- Part D claims, 2024
- 477
- Publications
- 14
- Clinical trials
- 10
- Practice address
- 4301 West Markham Street Mail Slot 612, Little Rock, AR 72205
- Practice phone
- Call (501) 686-5000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Govindarajan's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Rangaswamy Govindarajan is a hematology (internal medicine) physician in Little Rock, Arkansas
Dr. Govindarajan practices at UAMS Medical Center in Little Rock, Arkansas, part of University of Arkansas for Medical Sciences.
Dr. Govindarajan's NPI, 1831289313, was assigned on October 13, 2006. Dr. Govindarajan holds Arkansas license C-8513.
- NPI
- 1831289313NPI Registry (opens in a new tab)
- Medicare PAC ID
- 1254401714
- NPI enumeration date
- October 13, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (501) 686-5000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 72
- Medical school graduation
- 1980
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Rangaswamy Govindarajan practices at UAMS Medical Center in Little Rock, Arkansas
Dr. Govindarajan's primary practice is UAMS Medical Center, at 4301 West Markham Street Mail Slot 612, Little Rock, AR 72205 in Pulaski County. The practice phone is (501) 686-5000.
- UAMS Medical Center4301 West Markham Street Mail Slot 612, Little Rock, AR 72205 · Pulaski CountyPhone(501) 686-5000
Source: Dmand AI Affiliation Data
Dr. Rangaswamy Govindarajan is affiliated with 1 site of care and 3 medical groups
Dr. Govindarajan's primary practice is UAMS Medical Center in Little Rock, Arkansas, part of University of Arkansas for Medical Sciences. The medical group on file is UAMS - University of Arkansas for Medical Sciences. Dmand AI also links Dr. Govindarajan to 2 more medical groups, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Rangaswamy Govindarajan's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Govindarajan practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| UAMS Medical Center | Available with a free account |
| +2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across University of Arkansas for Medical Sciences and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Rangaswamy Govindarajan is one of 3 hematology (internal medicine) physicians in Arkansas
Internal medicine is Dr. Govindarajan's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Govindarajan is licensed in Arkansas.
Specialties and state licenses
- Hematology (internal medicine), ArkansasPrimary
Hematology (internal medicine) physicians near Dr. Govindarajan
Counts of hematology (internal medicine) physicians with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Rangaswamy Govindarajan billed Medicare for 453 services in 2024
CMS data shows 453 Medicare services from Dr. Govindarajan across 6 procedure codes in 2024, for 174 Medicare patients. Medicare paid $35,893 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Govindarajan's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 4642024: 4532%
Dr. Govindarajan's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Govindarajan?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Govindarajan and other hematology (internal medicine) physicians in Arkansas.
Source: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data
Dr. Rangaswamy Govindarajan treated 174 Medicare patients in 2024, average age 71
CMS counts 174 Medicare patients who saw Dr. Govindarajan in 2024. The largest group is 65 to 74, with 83 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Govindarajan's median patient age at 66, with 46% women.
Dr. Govindarajan's Medicare patients by age, 2024
Dr. Govindarajan's Medicare patients by sex, 2024
- Women8348%
- Men9152%
Chronic conditions among Dr. Govindarajan's Medicare patients, 2024
- High blood pressure75%
- High cholesterol66%
- Cancer63%
- Arthritis51%
- Diabetes34%
- Ischemic heart disease30%
- Chronic kidney disease29%
- Anxiety28%
Share of Medicare patients with each condition. A patient can have several.
Dr. Govindarajan's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 66
Patient panel by sex, all payers
- Women46%
- Men54%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Rangaswamy Govindarajan wrote 477 Medicare Part D claims in 2024
In 2024, Dr. Govindarajan wrote 477 Medicare Part D claims for 94 patients. 78% of them were for generic drugs. CMS names the drug for 305 of them, across 11 drugs with 11 or more claims each, at $426,446 in total drug cost. In 2023, CMS named 312 claims across 12 drugs.
Dr. Govindarajan's Part D claims by kind of drug, 2024
- Generic374 claims78%
- Brand-name103 claims22%
Dr. Govindarajan's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Govindarajan's Part D claims, 2024
- Opioids10%50 of 477 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 3122024: 3052%
Drugs named by CMS: 11 in 2024, 12 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. Rangaswamy Govindarajan takes part in Medicare
Dr. Govindarajan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Rangaswamy Govindarajan has 14 publications on record
Dmand AI links 14 papers to Dr. Govindarajan, published from 2007 to 2024. 2016 was the busiest year, with 2. The most frequent topics are Anti-Bacterial Agents and Antineoplastic Agents. Dr. Govindarajan has published most often in J Gastrointest Cancer. Dr. Govindarajan's most frequent co-authors are Charles David Blanke, MD, Eric Siegel, MD and Stephen K. Williamson, MD.
Dr. Govindarajan's papers by year, 2007 to 2024
Topics Dr. Govindarajan writes about most
- Anti-Bacterial Agents
- Antineoplastic Agents
Dr. Govindarajan's most frequent co-authors
- Charles David Blanke, MD2 shared papers
- Eric Siegel, MD2 shared papers
- Stephen K. Williamson, MD2 shared papers
Recent publications by Dr. Govindarajan
See who Dr. Govindarajan researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Govindarajan works with, so you can find a warm path to the right hematology (internal medicine) physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Rangaswamy Govindarajan has worked on 10 clinical trials
Dmand AI links Dr. Govindarajan to 10 clinical trials, 5 of them phase 3 studies. 9 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Melanoma. National Cancer Institute (NCI) sponsors the most, 9.
Clinical trials with Dr. Govindarajan by phase
- NonePhase 1: no trials
- 3Phase 2: 3 trials
- 1Phase 2/3: 1 trial
- 5Phase 3: 5 trials
- NonePhase 4: no trials
Conditions in Dr. Govindarajan's trials
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Bronchogenic
- Melanoma
- Nevi and Melanomas
- Anal Canal Carcinoma
Investigators on the most trials with Dr. Govindarajan
- Uzair Bashir Chaudhary, MD5 shared trials
- Christopher Haekang Chay, MD5 shared trials
- James E. Clarkson, MD5 shared trials
Recent clinical trials with Dr. Govindarajan
Testing the Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia (opens in a new tab)
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer (opens in a new tab)
FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer (opens in a new tab)
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial) (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Rangaswamy Govindarajan received $4,408 in industry payments from 2022 to 2025
CMS Open Payments shows 3 general payments to Dr. Govindarajan from 3 drug and device companies from 2022 to 2025. Consulting fees make up the largest share, 99% of the total. SpringWorks Therapeutics, Inc. paid the most, $3,000.
General payments to Dr. Govindarajan by program year, 2022 to 2025
General payments to Dr. Govindarajan by kind, 2022 to 2025
- Consulting fees$4,37599%
- Education$331%
Companies that paid Dr. Govindarajan the most, 2022 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Rangaswamy Govindarajan's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Rangaswamy Govindarajan
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Rangaswamy Govindarajan's NPI number?
Dr. Rangaswamy Govindarajan's NPI number is 1831289313. It was assigned on October 13, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Rangaswamy Govindarajan?
Dr. Rangaswamy Govindarajan is a hematology (internal medicine) physician in Little Rock, Arkansas. The primary specialty in the NPI Registry is Hematology (Internal Medicine) Physician (taxonomy code 207RH0000X).
Where does Dr. Rangaswamy Govindarajan practice?
Dr. Govindarajan practices at 4301 West Markham Street Mail Slot 612, Little Rock, AR 72205. Dr. Govindarajan's primary practice is UAMS Medical Center in Little Rock, Arkansas, part of University of Arkansas for Medical Sciences. Dmand AI also links Dr. Govindarajan to 2 medical groups.
What is Dr. Rangaswamy Govindarajan's office phone number?
The practice phone on file for Dr. Govindarajan is (501) 686-5000.
What is Dr. Rangaswamy Govindarajan's medical license number?
Dr. Govindarajan holds Arkansas license C-8513.
Which hospitals is Dr. Rangaswamy Govindarajan affiliated with?
Dr. Govindarajan practices at UAMS Medical Center in Little Rock, Arkansas.
What medical group is Dr. Rangaswamy Govindarajan part of?
Dr. Govindarajan is linked to UAMS - University of Arkansas for Medical Sciences. Dmand AI links Dr. Govindarajan to 2 more medical groups.
Does Dr. Rangaswamy Govindarajan accept Medicare?
Yes. CMS data shows Dr. Govindarajan billed Medicare for 453 services in 2024, and Dr. Govindarajan accepts Medicare assignment.
How many Medicare patients does Dr. Rangaswamy Govindarajan see?
CMS counts 174 Medicare patients who saw Dr. Govindarajan in 2024, with an average age of 71.
What services does Dr. Rangaswamy Govindarajan bill to Medicare?
In 2024, Dr. Govindarajan's most billed Medicare services were office visit, established patient (99215), office visit, established patient (99214) and office visit, established patient (99213).
Show 5 more questionsShow fewer questions
What drugs does Dr. Rangaswamy Govindarajan prescribe most?
In 2024 Medicare Part D data, Dr. Govindarajan's most prescribed drugs by claims were Ondansetron ODT, Potassium Chloride and Imatinib Mesylate.
Has Dr. Rangaswamy Govindarajan received payments from drug or device companies?
CMS Open Payments shows $4,408 in general payments to Dr. Govindarajan from 3 companies from 2022 to 2025. The largest total came from SpringWorks Therapeutics, Inc.
How long has Dr. Rangaswamy Govindarajan been practicing?
Dr. Govindarajan graduated from medical school in 1980, 46 years ago.
Does Dr. Rangaswamy Govindarajan do research?
Dmand AI links 14 publications to Dr. Govindarajan, published from 2007 to 2024. Dr. Govindarajan has worked on 10 clinical trials.
Who does Dr. Rangaswamy Govindarajan publish with?
Dr. Govindarajan's most frequent co-authors are Charles David Blanke, MD (2 shared papers), Eric Siegel, MD (2 shared papers) and Stephen K. Williamson, MD (2 shared papers).
Selling to internal medicine practices?
See hematology (internal medicine) physicians in Arkansas by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card